KROUZON PHARMACEUTICALS, INC. Press Releases

• Published on August 28, 2024 - 13:00 GMT

  

  Dr. Chris Senanayake Joins Krouzon Pharmaceuticals' Board of Directors

  Leading visionary scientific and business leader to accelerate development and path to market of Krouzon’s groundbreaking craniosynostosis and cancer therapies. NEW HAVEN, CONNECTICUT, USA, August 28, 2024 /⁨EINPresswire.com⁩/ -- Krouzon Pharmaceuticals, …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on January 10, 2024 - 20:00 GMT

  

  Krouzon Pharmaceuticals Enters R&D and Commercial Manufacturing Agreement with TCG GreenChem

  Agreement to help advance lead optimization and clinical development of drug candidates. NEW HAVEN, CONNECTICUT, U.S.A., January 10, 2024 /⁨EINPresswire.com⁩/ -- Krouzon Pharmaceuticals, Inc., a biotechnology company focusing on developing therapeutics …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...